Log in

Steris Stock Forecast, Price & News

-1.12 (-0.60 %)
(As of 10/26/2020 12:00 AM ET)
Today's Range
Now: $186.42
50-Day Range
MA: $176.31
52-Week Range
Now: $186.42
Volume185,871 shs
Average Volume593,254 shs
Market Capitalization$15.86 billion
P/E Ratio38.76
Dividend Yield0.85%
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment install, maintain, upgrade, repair, and troubleshoot services. This segment provides its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting and outsourced sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier products, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide and hydrogen peroxide; and laboratory testing services. It operates a network of approximately 50 facilities. The company was founded in 1985 and is based in Derby, the United Kingdom.
Read More
Steris logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.69 out of 5 stars

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$3.03 billion
Cash Flow$8.01 per share
Book Value$40.17 per share


Net Income$407.61 million


Market Cap$15.86 billion
Next Earnings Date11/2/2020 (Confirmed)
-1.12 (-0.60 %)
(As of 10/26/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Steris (NYSE:STE) Frequently Asked Questions

How has Steris' stock been impacted by Coronavirus?

Steris' stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, STE stock has increased by 28.3% and is now trading at $186.42.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Steris?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Steris

When is Steris' next earnings date?

Steris is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Steris

How can I listen to Steris' earnings call?

Steris will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) announced its quarterly earnings results on Monday, August, 3rd. The medical equipment provider reported $1.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.98 by $0.33. The medical equipment provider had revenue of $668.90 million for the quarter, compared to analyst estimates of $643.38 million. Steris had a net margin of 13.69% and a return on equity of 16.24%. The firm's quarterly revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.23 earnings per share.
View Steris' earnings history

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris announced a quarterly dividend on Monday, August 3rd. Investors of record on Thursday, August 27th will be paid a dividend of $0.40 per share on Thursday, September 24th. This represents a $1.60 annualized dividend and a dividend yield of 0.86%. The ex-dividend date of this dividend is Wednesday, August 26th. This is an increase from Steris's previous quarterly dividend of $0.37.
View Steris' dividend history

What price target have analysts set for STE?

4 analysts have issued twelve-month price targets for Steris' stock. Their forecasts range from $200.00 to $200.00. On average, they anticipate Steris' share price to reach $200.00 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price.
View analysts' price targets for Steris

Are investors shorting Steris?

Steris saw a increase in short interest in September. As of September 30th, there was short interest totaling 1,280,000 shares, an increase of 19.6% from the September 15th total of 1,070,000 shares. Based on an average daily trading volume, of 438,600 shares, the days-to-cover ratio is currently 2.9 days.
View Steris' Short Interest

Who are some of Steris' key competitors?

What other stocks do shareholders of Steris own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are Steris' key executives?

Steris' management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO & Pres (Age 65)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Director (Age 50)
  • Mr. Daniel A. Carestio, Chief Operating Officer (Age 46)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. & Director (Age 52)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 49)

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are Steris' major shareholders?

Steris' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.50%), Retirement Systems of Alabama (0.27%), Dearborn Partners LLC (0.24%), PGGM Investments (0.23%), Boston Trust Walden Corp (0.20%) and Fenimore Asset Management Inc. (0.12%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr.
View institutional ownership trends for Steris

Which institutional investors are selling Steris stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Denali Advisors LLC, State of Alaska Department of Revenue, Nisa Investment Advisors LLC, Xponance Inc., Copeland Capital Management LLC, MAI Capital Management, Dearborn Partners LLC, and Ellevest Inc.. Company insiders that have sold Steris company stock in the last year include Cary L Majors, Daniel A Carestio, John Adam Zangerle, Mohsen Sohi, Richard C Breeden, and Richard Martin Steeves.
View insider buying and selling activity for Steris

Which institutional investors are buying Steris stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Retirement Systems of Alabama, Envestnet Asset Management Inc., Jacobsen Capital Management, Stokes Capital Advisors LLC, Legato Capital Management LLC, Sequoia Financial Advisors LLC, and Fenimore Asset Management Inc..
View insider buying and selling activity for Steris

How do I buy shares of Steris?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Steris' stock price today?

One share of STE stock can currently be purchased for approximately $186.42.

How big of a company is Steris?

Steris has a market capitalization of $15.86 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

What is Steris' official website?

The official website for Steris is www.steris.com.

How can I contact Steris?

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.